Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Hemangioma 8Hemangioma, Capillary 7Melanoma 6Breast Neoplasms 5Carcinoma, Hepatocellular 4Sarcoma 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Multiple Myeloma 3Hypertension, Portal 3Hemangiosarcoma 3Fallopian Tube Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma, Kaposi 2Ovarian Neoplasms 2Hemangioma, Cavernous, Central Nervous System 2Colorectal Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Ulcer 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1

Interventions

Cisplatin 176Paclitaxel 79Radiotherapy 76Carboplatin 70Brachytherapy 69pembrolizumab 63Bevacizumab 40Gemcitabine 28Radiation 27Topotecan 26Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 25Nivolumab 22Colposcopy 22human papillomavirus vaccine, L1 type 16, 18 21Magnetic Resonance Spectroscopy 21atezolizumab 19Platinum 19Drug Therapy 19Papillomavirus Vaccines 18Radiotherapy, Intensity-Modulated 17Docetaxel 17Taxes 16Cyclophosphamide 16Biopsy 16Early Intervention, Educational 151,2-diaminocyclohexaneplatinum II citrate 15Methods 14Blood Specimen Collection 14fludarabine 13Injections 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Uterine Cervical Neoplasms × Propranolol × Clear all
NCT01902966 2021-10-12

Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)

M.D. Anderson Cancer Center

Phase NA Terminated
6 enrolled 8 charts
Gynecologic

Anxiety Disorders, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡